Blog14 August 2025 Navigating the eCOA Vendor Landscape in 2025: What Clinical Teams Really Need to Know The eCOA market reached $2.27 billion in 2025 with 16.1% projected growth, yet vendor selection remains critical for... Learn more
Blog7 August 2025 Optimizing eCOA in Oncology Trials: Patient-Focused Data Capture for Cancer Research Oncology leads clinical innovation with 7,747 trials registered through 2022, yet only 7% of cancer patients participate. This... Learn more
Blog31 July 2025 ePRO, eCOA 101: Everything You Need to Know About ePRO and eCOA Electronic Clinical Outcome Assessment (ECOA) and electronic Patient Reported Outcomes (ePRO) represent far more than digital surveys in... Learn more
Blog18 July 2025 Why eCOA Still Fails in Clinical Trials: Practical Strategies to Fix Baseline Data Problems Electronic clinical outcome assessments (eCOA) were supposed to solve data quality and amplify the patient voice. Yet missing... Learn more
Blog26 June 2025 How a 3-Person Team Got to Phase 3 — Without the Overhead Gameto proves you don’t need a large CRO or a floor of data managers to run complex global... Learn more
Webinar Broken at Baseline: Why eCOA Fails in the Real World (and Why We Don’t Talk About It) Why are baseline PROs still going uncaptured in 2025? Join Ari Gnanasakthy, Katja Rudell & Derk Arts to... Learn more
Blog28 May 2025 The New Standard in Participant-Centric Trials: What Castor’s 2025 Updates Reveal About the Future of Clinical Research Explore how Castor’s 2025 updates reduce site burden and boost compliance through scalable, flexible DTP workflows. Learn more
Success Stories19 May 2025 Oncobiomix: Slashing Costs and Elevating Data Quality Discover how Oncobiomix used an integrated platform for eConsent, EDC, and ePRO to save $100K and streamline data... Learn more
Webinar Product Spotlight: What’s New in 2025? Discover how Castor's latest product updates in 2025 can improve your day-to-day operations, and the participant experience. Learn more
Blog2 May 2025 Do Patients Really Understand Clinical Trials? Poor comprehension of informed consent disrupts trials. Here’s how to fix it—with data, tech, and actual patient understanding. Learn more
Blog3 April 2025 Why a Life Sciences Museum Matters—And What It Can Teach Us About the Future of Medicine What a Museum of Medicine can teach us about trials, trust, and how the public sees (or doesn’t... Learn more
News14 February 2025 Castor Steps Up to Preserve Critical Research Amid NIH Funding Cuts Castor has announced free access to its clinical trial technology platform for U.S. researchers impacted by recent NIH... Learn more
Success Stories29 January 2025 How Advanced Neuromodulation Researchers Cut Study Build Time by 63% Using Integrated Trial Technology This detailed case study reveals the practical strategies and technology solutions that enabled researchers to automate participant screening,... Learn more
Demos29 January 2025 Participant View eCOA | ePRO Reduce participant and site burden with a simple 2 step onboarding and user-friendly app. Secure questionnaires via email... Learn more
Factsheets27 January 2025 eCOA/ePRO factsheet Download our ePRO/eCOA factsheet to view an overview of our services. Learn more
Blog6 January 2025 Strategies to Minimize Participant and Healthcare Provider Burden in Clinical Trials This article examines strategies to reduce participant and provider burden in clinical trials while ensuring high-quality data collection.... Learn more
Blog30 December 2024 What do we measure with PROs in head and neck cancer? Pain, QoL, adverse events and more Patient-Reported Outcomes (PROs) are essential in head and neck cancer research, offering insights into symptoms, quality of life,... Learn more
Video20 December 2024 2024: Castor Year in Review As we close the year, the Castor team shares vital milestones the company has achieved to make patient-centric... Learn more
